EPISODE · Nov 17, 2021 · 19 MIN
Stock of the Week: Australian Clinical Labs (ASX:ACL), November 17, 2021
from Motley Fool Money · host LiSTNR
Scott is joined by Motley Fool Director of Research Kevin Gandiya to talk about pathology services growth story Australian Clinical Labs (ASX:ACL): What it does, what’s impressive, the risks of an investment in the company, and why he thinks it’s a Buy! See omnystudio.com/listener for privacy information.
Embed this episode
NOW PLAYING
Stock of the Week: Australian Clinical Labs (ASX:ACL), November 17, 2021
No transcript for this episode yet
Similar Episodes
No similar episodes found.